Faber F et al. |
Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. |
2016 |
Nature |
pmid:27309805
|
Tiwari P et al. |
Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs. |
2016 |
Biochimie |
pmid:26655363
|
Zager RA et al. |
Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. |
2016 |
Kidney Int. |
pmid:27165818
|
Montano-Pedroso JC et al. |
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:27068478
|
Han YM et al. |
Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. |
2016 |
Gut Liver |
pmid:27021505
|
Barbieri C et al. |
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. |
2016 |
PLoS ONE |
pmid:26939055
|
Bitsi S et al. |
Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:26670484
|
Nomoto H et al. |
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report. |
2017 |
Medicine (Baltimore) |
pmid:28953654
|
Deng Y et al. |
Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. |
2017 |
Med. Sci. Monit. |
pmid:28285317
|
Derman R et al. |
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. |
2017 |
Am. J. Hematol. |
pmid:28052413
|
Lee T et al. |
Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. |
2017 |
Gut |
pmid:26848182
|